Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement ...

AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...

MedPharm, a leader in topical and transdermal contract drug development and manufacturing, has appointed Bill Humphries as ...

Revance Therapeutics, Inc. faces financial struggles ... from Supernus Pharmaceuticals (SUPN), and Xeomin, from Merz Aesthetics — I concluded Revance may struggle to continue as a going concern ...

Merz Aesthetics, and others. .Promising Androgenetic Alopecia Therapies such as KX-826 (pyrilutamide), BREEZULA (clascoterone solution), FOL-005, Clascoterone solution 7.5%, and others.

Roche sees high single-digit core profit growth in 2025 Germany's government and opposition parties duelled on Monday over rival border control policies, with opposition leader Friedrich Merz ...

Five were based in the UK and one was based in Germany. Experts were interviewed individually by the sponsor (Merz Therapeutics GmbH) via 1-h video calls to understand how they assess people with arm ...